Novel Combination Of Lenalidomide-Rituximab Provides An Effective Bridge To Stem Cell Transplantation In Relapsed and/Or Refractory Aggressive B-Cell Non-Hodgkin's Lymphomas: A Single Center Experience

被引：0
|
作者：
Cai, Qingqing
Chen, Yiming
Zou, Dehui
Badillo, Maria
Zhou, Shouhao
Zhang, Liang
Lopez, Elyse R.
Jiang, Wenqi
Huang, Hui-qiang
Lin, Tongyu
Wang, Michael
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3056.3056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3056
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Single or double autologous stem cell transplantation for transformed aggressive B-cell non-Hodgkin's lymphoma
    Clavert, A.
    Roland, V.
    Le Gouill, S.
    Dubruille, V.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Devys, A.
    Flandrois, G.
    Saulquin, B.
    Moreau, A.
    Moreau, P.
    Harousseau, J. L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S211 - S211
  • [22] HIGH-DOSE VERSUS STANDARD-DOSE RITUXIMAB WITH BEAM IN AUTOLOGOUS STEM CELL TRANSPLANTATION (SCT) FOR RELAPSED AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMAS (NHL)
    Srour, S. A.
    Lozano, S.
    Nieto, Y.
    Alousi, A. M.
    Popat, U. R.
    Quazilbash, M. H.
    Anderlini, P.
    Kebriaei, P.
    Shpall, E.
    Champlin, R. E.
    Hosing, C.
    HAEMATOLOGICA, 2016, 101 : 114 - 114
  • [23] High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).
    Srour, Samer Ali
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Anderlini, Paolo
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Hosing, Chitra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center
    Sanchez-Gonzalez, Blanca
    Torres, Elena
    Ferraro Rosset, Mariana Paola
    Calafell, Montserrat
    Gale, Carmen
    Martinez, Laia
    Sancho, Esther
    Garcia, Pilar
    Gimeno, Eva
    Garcia-Pallarols, Francesc
    Salar, Antonio
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 1019 - 1021
  • [25] Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
    Ogura, Michinori
    Ando, Kiyoshi
    Taniwaki, Masafumi
    Watanabe, Takashi
    Uchida, Toshiki
    Ohmachi, Ken
    Matsumoto, Yosuke
    Tobinai, Kensei
    CANCER SCIENCE, 2011, 102 (09) : 1687 - 1692
  • [26] Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma
    Bertè, R
    Vallisa, D
    Civardi, G
    Moroni, CF
    Lazzaro, A
    Cavanna, L
    ACTA HAEMATOLOGICA, 2001, 106 (03) : 141 - 142
  • [27] Lenalidomide and Rituximab Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin Lymphoma Is Associated with Unacceptable Myelotoxicity
    Dean, Robert
    Pohlman, Brad
    Rybicki, Lisa
    Maggiotto, Amanda L.
    Bates, Jennifer
    Smith, Stephen D.
    Bolwell, Brian J.
    Sweetenham, John
    BLOOD, 2011, 118 (21) : 705 - 705
  • [28] Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
    Westin, Jason R.
    McLaughlin, Peter
    Romaguera, Jorge
    Hagemeister, Fredrick B.
    Pro, Barbara
    Dang, Nam H.
    Samaniego, Felipe
    Rodriguez, Maria A.
    Fayad, Luis
    Oki, Yasuhiro
    Fanale, Michelle
    Fowler, Nathan
    Nastoupil, Loretta
    Feng, Lei
    Loyer, Evelyn
    Younes, Anas
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (02) : 177 - 184
  • [29] Combination of plitidepsin and rituximab is effective for treatment of rituximab resistant Non-Hodgkin's B-cell lymphoma
    Barboza, Nora
    Medina, Daniel
    Budak, Tulin
    Aracil, Miguel
    Paz, Me
    Bertino, Joseph
    Banerjee, Debabrata
    CANCER RESEARCH, 2009, 69
  • [30] Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation
    Vose, Julie M.
    Habermann, Thomas M.
    Czuczman, Myron S.
    Zinzani, Pier Luigi
    Reeder, Craig B.
    Tuscano, Joseph M.
    Lossos, Izidore S.
    Li, Ju
    Pietronigro, Dennis
    Witzig, Thomas E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (05) : 639 - 647
12345